They also and supported a clinical student for her research project on her elective at the University of Sydney, in 2013.

On the 2nd December 2014, the trustees supported a session at the Progress Educational Trust annual conference on The Commercialisation of Life, held at London's Institute of Child Health. The session comprised a panel consisting of Dr Claire Gerada, Dr Stuart Hogarth, Dr Kari Stefánsson and Vivienne Parry discussed the future of healthcare in a world where genetics, technology and 'Big Data' are increasingly centre stage. This session could not have been better timed, as the conference coincided with the UK launch of a direct-to-consumer genetic test by the company 23andMe.

On the 7th December 2015, the trustees supported a session entitled “Three-person IVF?“ at the Progress Educational Trust annual conference on From Three-Person IVF to Genome Editing: The Science and Ethics of Engineering the Embryo, held at London's Institute of Child Health. First off in the session was Doug Turnbull, Director Wellcome Trust Centre for Mitochondrial Research, who spoke about the clinical need for mitochondrial donation? He was followed by Dame Sally Cheshire, Chair of the HFEA, who spoke about the regulatory position and why that makes the UK the best place for research on and treatment with mitochondrial donation. The last speaker was Viscount Matt Ridley, who described the way the House of Lords handled the legislation.